ARCT · Arcturus Therapeutics Holdings Inc
United States · RS rating 70 · As of 2026-10-14
| Price | 11.12 USD |
|---|---|
| 1-day change | -7.6% |
| RS rating (overall / 1M / 3M / 12M) | 70 / 6 / 97 / 16 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 23 / 32 / 18 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | -110.2% |
| Sales growth Q/Q | -78.2% |
| Distance from 52-week high | +52.0% |
| Market cap (USD) | $240.7M |